{"id":"https://openalex.org/W2810048175","doi":"https://doi.org/10.14814/phy2.13753","title":"Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury","display_name":"Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury","alternate_titles":[],"publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2810048175","doi":"https://doi.org/10.14814/phy2.13753","mag":"2810048175","pmid":"https://pubmed.ncbi.nlm.nih.gov/29952109","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6021279"},"language":"en","primary_location":{"id":"doi:10.14814/phy2.13753","doi":"https://doi.org/10.14814/phy2.13753","is_oa":true,"landing_page_url":"https://doi.org/10.14814/phy2.13753","pdf_url":"https://physoc.onlinelibrary.wiley.com/doi/pdfdirect/10.14814/phy2.13753","source":{"id":"https://openalex.org/S91696817","display_name":"Physiological Reports","issn_l":"2051-817X","issn":["2051-817X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Physiological Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2810048175"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://physoc.onlinelibrary.wiley.com/doi/pdfdirect/10.14814/phy2.13753","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030495374","display_name":"Thomas H. Sisson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Thomas H. Sisson","raw_affiliation_strings":["Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058958703","display_name":"Paul J. Christensen","orcid":"https://orcid.org/0000-0002-6827-621X","observed_orcids":["https://orcid.org/0000-0002-6827-621X"]},"institutions":[{"id":"https://openalex.org/I2799370151","display_name":"Beaumont Health","ror":"https://ror.org/05g2hd893","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2799370151","https://openalex.org/I4392738273"]},{"id":"https://openalex.org/I4210161005","display_name":"Beaumont Hospital, Troy","ror":"https://ror.org/05x9ffc66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210161005","https://openalex.org/I4392738273"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul J. Christensen","raw_affiliation_strings":["Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, William Beaumont Medical Center, Troy, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, William Beaumont Medical Center, Troy, Michigan","institution_ids":["https://openalex.org/I2799370151","https://openalex.org/I4210161005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069536207","display_name":"Yo Muraki","orcid":"https://orcid.org/0000-0001-6891-3074","observed_orcids":["https://orcid.org/0000-0001-6891-3074"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yo Muraki","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070140437","display_name":"Anthony J. Dils","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony J. Dils","raw_affiliation_strings":["Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032002368","display_name":"Lauren N. Chibucos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lauren Chibucos","raw_affiliation_strings":["Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026823954","display_name":"Natalya Subbotina","orcid":"https://orcid.org/0000-0002-1766-9726","observed_orcids":["https://orcid.org/0000-0002-1766-9726"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Natalya Subbotina","raw_affiliation_strings":["Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039082764","display_name":"Kimio Tohyama","orcid":"https://orcid.org/0000-0002-7275-5790","observed_orcids":["https://orcid.org/0000-0002-7275-5790"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kimio Tohyama","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022475245","display_name":"Jeffrey Craig Horowitz","orcid":"https://orcid.org/0000-0002-1505-2837","observed_orcids":["https://orcid.org/0000-0002-1505-2837"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey C. Horowitz","raw_affiliation_strings":["Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary and Critical Care Division, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108468554","display_name":"Takanori Matsuo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takanori Matsuo","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108694961","display_name":"Marc B. Bailie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Bailie","raw_affiliation_strings":["In Vivo Facility, Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"In Vivo Facility, Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023232564","display_name":"Sham S. Nikam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sham Nikam","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111963078","display_name":"Masatoshi Hazama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masatoshi Hazama","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5030495374"],"corresponding_institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"],"apc_list":{"value":2050,"currency":"USD","value_usd":2050},"apc_paid":{"value":2050,"currency":"USD","value_usd":2050},"fwci":3.431,"has_fulltext":true,"cited_by_count":68,"citation_normalized_percentile":{"value":0.93191399,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"6","issue":"12","first_page":"e13753","last_page":"e13753"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.04320000112056732,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.949999988079071},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.9520000219345093},{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.843999981880188},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.8220000267028809},{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":0.9139999747276306},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":1.0},{"id":"https://openalex.org/keywords/surfactant-protein-d","display_name":"surfactant protein D","score":0.9860000014305115},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.984000027179718}],"concepts":[{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.953849732875824},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.9085687398910522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8427523374557495},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.7352161407470703},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.6419782042503357},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.5469146966934204},{"id":"https://openalex.org/C2778926808","wikidata":"https://www.wikidata.org/wiki/Q693482","display_name":"Roflumilast","level":3,"score":0.5407915115356445},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5042170286178589},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4577854871749878},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33174630999565125},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.25924980640411377}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011658","descriptor_name":"Pulmonary Fibrosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011658","descriptor_name":"Pulmonary Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011658","descriptor_name":"Pulmonary Fibrosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018925","descriptor_name":"Chemokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D037663","descriptor_name":"Pulmonary Surfactant-Associated Protein D","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D056809","descriptor_name":"Alveolar Epithelial Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D058988","descriptor_name":"Phosphodiesterase 4 Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058988","descriptor_name":"Phosphodiesterase 4 Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D058988","descriptor_name":"Phosphodiesterase 4 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.14814/phy2.13753","doi":"https://doi.org/10.14814/phy2.13753","is_oa":true,"landing_page_url":"https://doi.org/10.14814/phy2.13753","pdf_url":"https://physoc.onlinelibrary.wiley.com/doi/pdfdirect/10.14814/phy2.13753","source":{"id":"https://openalex.org/S91696817","display_name":"Physiological Reports","issn_l":"2051-817X","issn":["2051-817X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Physiological Reports","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4972241","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6021279","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6021279","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6021279/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Physiol Rep","raw_type":"Text"},{"id":"pmid:29952109","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29952109","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Physiological reports","raw_type":"Journal Article"},{"id":"pmh:oai:deepblue.lib.umich.edu:2027.42/144679","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2027.42/144679","pdf_url":null,"source":{"id":"https://openalex.org/S4306400393","display_name":"Deep Blue (University of Michigan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I27837315","host_organization_name":"University of Michigan","host_organization_lineage":["https://openalex.org/I27837315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.14814/phy2.13753","doi":"https://doi.org/10.14814/phy2.13753","is_oa":true,"landing_page_url":"https://doi.org/10.14814/phy2.13753","pdf_url":"https://physoc.onlinelibrary.wiley.com/doi/pdfdirect/10.14814/phy2.13753","source":{"id":"https://openalex.org/S91696817","display_name":"Physiological Reports","issn_l":"2051-817X","issn":["2051-817X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Physiological Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1144059356","display_name":"Somatomedin B Binding of Plasminogen Activator Inhibitor-1 in Pulmonary Fibrosis","funder_award_id":"R01HL078871","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G3416273563","display_name":"X-Linked Inhibitor of Apoptosis in Fibroblast Phenotypes and Lung Fibrosis","funder_award_id":"R01HL141195","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2810048175.pdf","grobid_xml":"https://content.openalex.org/works/W2810048175.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1655403557","https://openalex.org/W1686192005","https://openalex.org/W1744869172","https://openalex.org/W1938547050","https://openalex.org/W1978158142","https://openalex.org/W1989622233","https://openalex.org/W1996883499","https://openalex.org/W1997666213","https://openalex.org/W2002203472","https://openalex.org/W2005477943","https://openalex.org/W2019525573","https://openalex.org/W2021310863","https://openalex.org/W2026501434","https://openalex.org/W2027691370","https://openalex.org/W2037034743","https://openalex.org/W2050039599","https://openalex.org/W2051479586","https://openalex.org/W2053069335","https://openalex.org/W2065977597","https://openalex.org/W2071855864","https://openalex.org/W2078023796","https://openalex.org/W2090066471","https://openalex.org/W2094580915","https://openalex.org/W2098977806","https://openalex.org/W2101960743","https://openalex.org/W2102052809","https://openalex.org/W2106024776","https://openalex.org/W2115141581","https://openalex.org/W2125639937","https://openalex.org/W2125667200","https://openalex.org/W2131813265","https://openalex.org/W2132051696","https://openalex.org/W2133907923","https://openalex.org/W2134764292","https://openalex.org/W2136114918","https://openalex.org/W2138871107","https://openalex.org/W2139777957","https://openalex.org/W2140386277","https://openalex.org/W2143188326","https://openalex.org/W2164134225","https://openalex.org/W2168666423","https://openalex.org/W2305729794","https://openalex.org/W2346999058","https://openalex.org/W2396020517","https://openalex.org/W2406225731","https://openalex.org/W2606309368","https://openalex.org/W2792301413"],"related_works":["https://openalex.org/W4321499929","https://openalex.org/W7129015747","https://openalex.org/W4405983946","https://openalex.org/W6907569012","https://openalex.org/W2009480696","https://openalex.org/W3081472252","https://openalex.org/W7132833716","https://openalex.org/W4402062073","https://openalex.org/W7166707561","https://openalex.org/W4387970599"],"abstract_inverted_index":{"Fibrosis":[0],"of":[1,25,50,65,81,95,115,145,162,190,209,221,231],"the":[2,16,22,48,63,79,112,119,146,151,160,171,206],"lung":[3,96,155,174,214,241],"constitutes":[4],"a":[5,86,92,101,168,195,203,235],"major":[6],"clinical":[7,31],"challenge":[8],"and":[9,19,130,139,154,184,216],"novel":[10,87],"therapies":[11,121],"are":[12,28,123,159],"required":[13],"to":[14,37,118,182],"alleviate":[15],"associated":[17],"morbidity":[18],"mortality.":[20],"Investigating":[21],"antifibrotic":[23,67,113],"efficacy":[24,80],"drugs":[26,191],"that":[27,69,98,122,134,158],"already":[29],"in":[30,91,173,194,197,205,213,218],"practice":[32],"offers":[33],"an":[34,217],"efficient":[35],"strategy":[36],"identify":[38],"new":[39],"therapies.":[40],"The":[41],"phosphodiesterase":[42],"4":[43],"(PDE4)":[44],"inhibitors,":[45],"approved":[46],"for":[47,58,125,237],"treatment":[49,236],"chronic":[51],"obstructive":[52],"pulmonary":[53,59,127],"disease,":[54],"harbor":[55],"therapeutic":[56,140,169],"potential":[57],"fibrosis":[60,97,128,175],"by":[61],"augmenting":[62],"activity":[64,114],"endogenous":[66],"mediators":[68],"signal":[70],"through":[71],"cyclic":[72],"AMP.":[73],"In":[74,167],"this":[75,188],"study,":[76],"we":[77],"tested":[78],"several":[82,210],"PDE4":[83,116,147,177,232],"inhibitors":[84,148],"including":[85],"compound":[88],"(Compound":[89],"1)":[90],"murine":[93],"model":[94],"results":[99,227],"from":[100],"targeted":[102,163],"type":[103],"II":[104],"alveolar":[105],"epithelial":[106,164],"cell":[107,165],"injury.":[108],"We":[109,132],"also":[110,192],"compared":[111],"inhibition":[117,220,233],"two":[120],"FDA-approved":[124],"idiopathic":[126],"(pirfenidone":[129],"nintedanib).":[131],"found":[133],"both":[135],"preventative":[136],"(day":[137,141],"0-21)":[138],"11-21)":[142],"dosing":[143],"regimens":[144],"significantly":[149],"ameliorated":[150],"weight":[152],"loss":[153],"collagen":[156],"accumulation":[157],"sequelae":[161],"damage.":[166],"protocol,":[170],"reduction":[172,204],"with":[176,187,239],"inhibitor":[178],"administration":[179],"was":[180],"equivalent":[181],"pirfenidone":[183],"nintedanib.":[185],"Treatment":[186],"class":[189],"resulted":[193],"decrease":[196],"plasma":[198,207],"surfactant":[199],"protein":[200],"D":[201],"concentration,":[202],"levels":[208],"chemokines":[211],"implicated":[212],"fibrosis,":[215],"vitro":[219],"fibroblast":[222],"profibrotic":[223],"gene":[224],"expression.":[225],"These":[226],"motivate":[228],"further":[229],"investigation":[230],"as":[234],"patients":[238],"fibrotic":[240],"disease.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2810048175","counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-07-10T00:00:00"}
